Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06805630 · ClinicalTrials.gov registry record · NA
Urine Methylation Markers in UTUC
A NA study of Upper Tract Urothelial Cancer, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06805630 is a NA study of Upper Tract Urothelial Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06805630, a NA study of Upper Tract Urothelial Cancer, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to measure DNA markers in the urine of patients with upper tract urothelial cancer (UTUC) before surgery and during follow-up visits. Identifying these DNA markers could improve diagnosis before surgery, help assess risk, and predict early recurrence of the cancer. Urine samples will be de-identified and sent to Pangea Laboratory LLC for analysis. The results of this test will be compared to the traditional tests in upper tract urothelial cancer, such as cells in the urine and tissue biopsy.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Bladder CARE™
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-05-07 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06805630
The ClinicalTrials.gov registry entry for NCT06805630 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Upper Tract Urothelial Cancer appearing as the primary indexed condition, and to 1 intervention - of which Bladder CARE™ is the first listed.
NCT06805630 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06805630 about?
NCT06805630 is a clinical study titled "Urine Methylation Markers in UTUC". This is a research study to measure DNA markers in the urine of patients with upper tract urothelial cancer (UTUC) before surgery and during follow-up visits. Identifying these DNA markers could improve diagnosis before surgery, help assess risk, and predict early recurrence of the cancer. Urine sam...
What is the current status of trial NCT06805630?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-05-07. Estimated completion is 2026-06.
What conditions does trial NCT06805630 study?
This clinical trial studies the following conditions: Upper Tract Urothelial Cancer.
What interventions are being tested in trial NCT06805630?
The interventions under investigation include: Bladder CARE™ (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06805630?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06805630 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.